McMullen Michael R. bought BMY
June 30, 2026 · Form 4 insider transaction
McMullen Michael R. bought 607.428 shares of Bristol-Myers Squibb Company at $57.62 per share, a transaction worth $35.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
607.428
Price
$57.62
Total value
$35.0K
InsiderMcMullen Michael R.
Role—
SecurityDeferred Share Units
Transaction codeA: Grant or award
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after16,333
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.; Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.